Clinical Trial Update: NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated nicotinamide adenine dinucleotide (NAD) therapy for improving memory and brain blood flow in older adults with mi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Nicotinamide adenine dinucleotide (NAD) therapy (Nicotinamide adenine dinucleotide)

Snippet

Sponsor: University of Delaware | Conditions: Mild Cognitive Impairment | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-04